Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | Cellular & Molecular Biology Letters

Fig. 2

From: Oncogenic circ-SLC16A1 promotes progression of non-small cell lung cancer via regulation of the miR-1287-5p/profilin 2 axis

Fig. 2

Downregulation of circ-SLC16A1 inhibited the proliferation ability of NSCLC cells. A RT-qPCR detection showed the expression of circ-SLC16A1 in BEAS-2B, A549, and H1833 cells. Data shown as mean ± SD. ***P < 0.001 versus BEAS-2B. B RT-qPCR detection showed the expression of circ-SLC16A1 in both A549 and H1833 cells after transfection with siRNA against circ-SLC16A1. C–F Flow cytometry for cell cycle detection. Data shown as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 versus NC. G and H CCK8 detection showed the proliferation ability of both A549 and H1833 cells. Data shown as mean ± SD. ***P < 0.001 versus NC. I and J Clone formation showed the proliferation ability in both A549 and H1833 cells. Data shown as mean ± SD. **P < 0.01, ***P < 0.001 versus NC. K and L EdU detection showed the proliferation ability in both A549 and H1833 cells. Data shown as mean ± SD. *P < 0.05, **P < 0.01 versus NC

Back to article page

Cellular & Molecular Biology Letters

ISSN: 1689-1392

Contact us